pI: 4.9737 |
Length (AA): 486 |
MW (Da): 53884 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
3 | 438 | 4u3j (A) | 2 | 438 | 39.00 | 0 | 1 | 1.44512 | -0.81 |
3 | 438 | 4u3j (B) | 2 | 427 | 33.00 | 0 | 1 | 1.34612 | -0.82 |
4 | 436 | 2bto (A) | 5 | 430 | 28.00 | 0 | 1 | 1.24975 | -0.63 |
4 | 456 | 2btq (A) | 5 | 440 | 29.00 | 0 | 1 | 1.2699 | -0.38 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_240205)
Species | Accession | Gene Product |
---|---|---|
Neospora caninum | NCLIV_031660 | tubulin alpha chain, putative |
Toxoplasma gondii | TGME49_231400 | tubulin/FtsZ family, GTPase domain-containing protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
TGME49_231400 | Toxoplasma gondii | Probably non-essential | sidik |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Leishmania major | beta tubulin | 443 aa | 32.1% | 433 aa | Compounds | References |
Sus scrofa | Tubulin alpha chain | 451 aa | 37.4% | 436 aa | Compounds | References |
Trypanosoma brucei | tubulin gamma chain | 447 aa | 29.5% | 447 aa | Compounds | References |
Plasmodium falciparum | alpha tubulin 1 | 453 aa | 39.1% | 432 aa | Compounds | References |
Leishmania major | beta tubulin | 443 aa | 32.1% | 433 aa | Compounds | References |
Bos taurus | Tubulin | 445 aa | 30.9% | 433 aa | Compounds | References |
Leishmania major | gamma-tubulin | 447 aa | 30.2% | 410 aa | Compounds | References |
Rattus norvegicus | Tubulin alpha-1 chain | 451 aa | 37.4% | 436 aa | Compounds | References |
Trypanosoma brucei | alpha tubulin | 451 aa | 38.2% | 432 aa | Compounds | References |
Trypanosoma brucei | beta tubulin | 442 aa | 31.9% | 436 aa | Compounds | References |
Leishmania major | alpha tubulin | 451 aa | 38.9% | 432 aa | Compounds | References |
Bos taurus | Tubulin beta chain | 445 aa | 30.9% | 433 aa | Compounds | References |
Bos taurus | Tubulin | 85 aa | 40.2% | 87 aa | Compounds | References |
Leishmania major | beta tubulin | 443 aa | 32.1% | 433 aa | Compounds | References |
Trypanosoma brucei | alpha tubulin | 451 aa | 38.2% | 432 aa | Compounds | References |
Leishmania major | alpha tubulin | 451 aa | 38.9% | 432 aa | Compounds | References |
Trypanosoma brucei | alpha tubulin | 451 aa | 38.2% | 432 aa | Compounds | References |
Leishmania major | beta tubulin | 443 aa | 32.1% | 433 aa | Compounds | References |
Leishmania major | alpha tubulin | 451 aa | 38.9% | 432 aa | Compounds | References |
Leishmania major | beta tubulin | 443 aa | 32.1% | 433 aa | Compounds | References |
Leishmania major | alpha tubulin | 451 aa | 38.9% | 432 aa | Compounds | References |
Leishmania major | beta tubulin | 443 aa | 32.1% | 433 aa | Compounds | References |
Leishmania major | beta tubulin | 443 aa | 32.1% | 433 aa | Compounds | References |
Leishmania major | beta tubulin | 443 aa | 32.1% | 433 aa | Compounds | References |
Leishmania major | alpha tubulin | 451 aa | 38.9% | 432 aa | Compounds | References |
Leishmania major | beta tubulin | 443 aa | 32.1% | 433 aa | Compounds | References |
Sus scrofa | Tubulin | 445 aa | 30.9% | 433 aa | Compounds | References |
Ovis aries | Tubulin alpha 4a | 448 aa | 38.1% | 449 aa | Compounds | References |
Leishmania major | alpha tubulin | 451 aa | 38.9% | 432 aa | Compounds | References |
Leishmania major | alpha tubulin | 451 aa | 38.9% | 432 aa | Compounds | References |
Leishmania major | alpha tubulin | 451 aa | 38.9% | 432 aa | Compounds | References |
Plasmodium falciparum | tubulin beta chain | 445 aa | 33.2% | 434 aa | Compounds | References |
Leishmania major | beta tubulin | 443 aa | 32.1% | 433 aa | Compounds | References |
Leishmania major | epsilon tubulin, putative | 470 aa | 29.0% | 472 aa | Compounds | References |
Leishmania major | beta tubulin | 443 aa | 32.1% | 433 aa | Compounds | References |
Leishmania major | alpha tubulin | 451 aa | 38.9% | 432 aa | Compounds | References |
Leishmania major | beta tubulin | 443 aa | 32.1% | 433 aa | Compounds | References |
Trypanosoma brucei | alpha tubulin | 451 aa | 38.2% | 432 aa | Compounds | References |
Leishmania major | beta tubulin | 443 aa | 32.1% | 433 aa | Compounds | References |
Leishmania major | alpha tubulin | 451 aa | 38.9% | 432 aa | Compounds | References |
Leishmania major | alpha tubulin | 451 aa | 38.9% | 432 aa | Compounds | References |
Leishmania major | alpha tubulin | 451 aa | 38.9% | 432 aa | Compounds | References |
Leishmania major | beta tubulin | 443 aa | 32.1% | 433 aa | Compounds | References |
Leishmania major | beta tubulin | 443 aa | 32.1% | 433 aa | Compounds | References |